SCHEMBL3847172

SCHEMBL3847172

OC12C(F)(F)C3(O)C(F)(F)C(O)(C1(F)F)C(F)(F)C(F)(C2(F)F)C3(F)F

nearest known ligand 0.33

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 1/20 0.33
KMT2A Q03164 1/20 0.33
TDP1 Q9NUW8 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL820267 0.96 MEN1 (0.31) MEN1KMT2ATDP1
SCHEMBL1395211 0.92 MEN1 (0.33) MEN1KMT2ATDP1
SCHEMBL3843949 0.87 MEN1 (0.31) MEN1KMT2ATDP1
SCHEMBL3843953 0.76
SCHEMBL4332236 0.73
Methacrylic Acid SCHEMBL3847173 0.72
SCHEMBL13913354 0.69 MEN1 (0.32) MEN1KMT2ATDP1
SCHEMBL1888715 0.67 MEN1 (0.33) MEN1KMT2ATDP1
SCHEMBL4410924 0.66 MEN1 (0.67) MEN1KMT2ATDP1
SCHEMBL708310 0.66 MEN1 (0.50) MEN1KMT2ATDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090148706-A1 OPTICAL WAVEGUIDE HAVING PERFLUOROADAMANTANE STRUCTURE OMRON CORPORATION (JP) 2009-06-11 US disclosed
US-7511177-B2 Fluoroadamantane derivative ASAHI GLASS COMPANY, LIMITED (JP) 2009-03-31 US disclosed
US-7511177-B2 Fluoroadamantane derivative ASAHI GLASS COMPANY, LIMITED (JP) 2009-03-31 US disclosed
US-7488847-B2 Fluorinated adamantane and its derivatives ASAHI GLASS COMPANY, LIMITED (JP) 2009-02-10 US disclosed
US-7488847-B2 Fluorinated adamantane and its derivatives ASAHI GLASS COMPANY, LIMITED (JP) 2009-02-10 US disclosed
EP-2015113-A1 OPTICAL WAVEGUIDE HAVING PERFLUOROADAMANTANE STRUCTURE Omron Corporation (JP) 2009-01-14 EP disclosed
US-7402714-B2 Fluoroadamantane derivative ASAHI GLASS COMPANY, LIMITED (JP) 2008-07-22 US disclosed
US-7402714-B2 Fluoroadamantane derivative ASAHI GLASS COMPANY, LIMITED (JP) 2008-07-22 US disclosed
US-20080132736-A1 FLUOROADAMANTANE DERIVATIVE ASAHI GLASS COMPANY, LIMITED (JP) 2008-06-05 US disclosed
US-20080132736-A1 FLUOROADAMANTANE DERIVATIVE ASAHI GLASS COMPANY, LIMITED (JP) 2008-06-05 US disclosed
US-20080071033-A1 Fluoropolymer having a group capable of reacting with an epoxy group or an acid anhydride, a fluorinated compound having an epoxy group, and an acid anhydride; fluorinated adamantane substituted with glycidyl ether; white light emitting diode ASAHI GLASS CO., LTD. (JP) 2008-03-20 US disclosed
US-20070129566-A1 FLUOROADAMANTANE DERIVATIVE ASAHI GLASS COMPANY, LIMITED (JP) 2007-06-07 US disclosed
US-20070129566-A1 FLUOROADAMANTANE DERIVATIVE ASAHI GLASS COMPANY, LIMITED (JP) 2007-06-07 US disclosed
EP-1757575-A1 FLUOROADAMANTANE DERIVATIVE Asahi Glass Company, Limited (JP) 2007-02-28 EP disclosed
EP-1460057-B1 PERFLUOROADAMANTYL ACRYLATE COMPOUND AND INTERMEDIATE THEREFOR IDEMITSU KOSAN CO (JP) 2006-12-13 EP disclosed
US-7084295-B2 Perfluoroadamantyl acrylate compound and intermediate therefor IDEMITSU KOSAN CO., LTD. (JP) 2006-08-01 US disclosed
US-20050288528-A1 Fluorinated adamantane and its derivatives ASAHI GLASS COMPANY LIMITED (JP) 2005-12-29 US disclosed
US-20050131247-A1 Perfluoroadamantly acrylate compound and intermediate therefor IDEMITDU PETROCHEMICAL CO., LTD (JP) 2005-06-16 US disclosed
EP-1460057-A1 PERFLUOROADAMANTYL ACRYLATE COMPOUND AND INTERMEDIATE THEREFOR IDEMITSU PETROCHEMICAL CO., LTD. (JP) 2004-09-22 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050131247-A1 Perfluoroadamantly acrylate compound and intermediate therefor FFAR3, PFAS, FFAR1 MEN1 1992/4885KMT2A 1359/4885TDP1 2871/4885
US-20050288528-A1 Fluorinated adamantane and its derivatives ADH1A, AFF1, ADH5 MEN1 2092/4885KMT2A 2346/4885TDP1 1215/4885
US-20080132736-A1 FLUOROADAMANTANE DERIVATIVE AFF1, AFF2, AFF4 MEN1 1727/4885KMT2A 922/4885TDP1 821/4885
US-20070129566-A1 FLUOROADAMANTANE DERIVATIVE AFF1, AFF2, AFF4 MEN1 1727/4885KMT2A 922/4885TDP1 821/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.